Related Experiment Videos
Cytologic features of proliferative breast disease: a study designed to minimize sampling error
A R Frost1, S O Tabbara, L A Poprocky
1University of Alabama at Birmingham, Birmingham, Alabama 35233, USA.
Cancer
|February 26, 2000
Summary
Cytologic features can distinguish proliferative breast disease with atypia (PBDA)/DCIS from nonproliferative breast disease (NPBD)/proliferative breast disease (PBD). However, differentiating NPBD from PBD using cytology alone is challenging.
Area of Science:
- Pathology
- Cytopathology
- Breast Cancer Research
Background:
- Accurate classification of proliferative breast disease (PBD) is crucial for patient management.
- Fine-needle aspiration (FNA) cytology can be limited by sampling errors when compared to histology.
- Optimizing cytohistologic correlation is essential for reliable breast lesion assessment.
Purpose of the Study:
- To evaluate specific cytologic features for differentiating various categories of proliferative breast disease.
- To improve the accuracy of classifying breast lesions using cytopathology.
Main Methods:
- Two smears (H&E and Diff-Quik) were prepared from 98 breast biopsies.
- Smears were blindly reviewed for cellularity, background, cell groups, and nuclear features.
- Cytologic classifications were compared with corresponding histologic sections.
Main Results:
- Smears from atypia/DCIS showed higher cellularity, single cells, necrosis, nuclear overlap, and specific nuclear features (large nuclei, macronucleoli, pleomorphism, clumped chromatin, hyperchromasia).
- Smears from atypia/DCIS were less likely to have complex cell groups, monolayers, and myoepithelial cells.
- Smears from PBD showed larger and more complex cell groups compared to NPBD, but other features were similar.
Conclusions:
- Distinct cytologic features allow differentiation between nonproliferative/proliferative breast disease and proliferative breast disease with atypia/DCIS.
- Few cytologic features effectively distinguish nonproliferative breast disease from proliferative breast disease without atypia.